nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.211	0.463	CbGbCtD
Darunavir—CYP3A4—Progesterone—uterine cancer	0.14	0.307	CbGbCtD
Darunavir—CYP3A4—Etoposide—uterine cancer	0.0625	0.137	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—uterine cancer	0.0426	0.0936	CbGbCtD
Darunavir—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000407	0.000747	CcSEcCtD
Darunavir—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000407	0.000747	CcSEcCtD
Darunavir—Nasopharyngitis—Epirubicin—uterine cancer	0.000404	0.000742	CcSEcCtD
Darunavir—Hypersensitivity—Dactinomycin—uterine cancer	0.000403	0.000741	CcSEcCtD
Darunavir—Gastritis—Epirubicin—uterine cancer	0.0004	0.000735	CcSEcCtD
Darunavir—Confusional state—Etoposide—uterine cancer	0.000399	0.000734	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000399	0.000732	CcSEcCtD
Darunavir—Muscular weakness—Epirubicin—uterine cancer	0.000399	0.000732	CcSEcCtD
Darunavir—Mood swings—Doxorubicin—uterine cancer	0.000396	0.000727	CcSEcCtD
Darunavir—Abdominal distension—Epirubicin—uterine cancer	0.000393	0.000722	CcSEcCtD
Darunavir—Asthenia—Dactinomycin—uterine cancer	0.000393	0.000721	CcSEcCtD
Darunavir—Blood creatinine increased—Doxorubicin—uterine cancer	0.000392	0.000719	CcSEcCtD
Darunavir—Thrombocytopenia—Etoposide—uterine cancer	0.000388	0.000713	CcSEcCtD
Darunavir—Tachycardia—Etoposide—uterine cancer	0.000387	0.00071	CcSEcCtD
Darunavir—Eosinophilia—Epirubicin—uterine cancer	0.000387	0.00071	CcSEcCtD
Darunavir—Liver function test abnormal—Doxorubicin—uterine cancer	0.000386	0.000709	CcSEcCtD
Darunavir—Skin disorder—Etoposide—uterine cancer	0.000385	0.000707	CcSEcCtD
Darunavir—Dry skin—Doxorubicin—uterine cancer	0.000383	0.000704	CcSEcCtD
Darunavir—Hyperhidrosis—Etoposide—uterine cancer	0.000383	0.000703	CcSEcCtD
Darunavir—Pancreatitis—Epirubicin—uterine cancer	0.000383	0.000703	CcSEcCtD
Darunavir—Angina pectoris—Epirubicin—uterine cancer	0.00038	0.000699	CcSEcCtD
Darunavir—Breast disorder—Doxorubicin—uterine cancer	0.000378	0.000694	CcSEcCtD
Darunavir—Anorexia—Etoposide—uterine cancer	0.000378	0.000694	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000376	0.000692	CcSEcCtD
Darunavir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000376	0.000692	CcSEcCtD
Darunavir—Diarrhoea—Dactinomycin—uterine cancer	0.000375	0.000688	CcSEcCtD
Darunavir—Nasopharyngitis—Doxorubicin—uterine cancer	0.000374	0.000687	CcSEcCtD
Darunavir—Pancytopenia—Epirubicin—uterine cancer	0.000371	0.000681	CcSEcCtD
Darunavir—Gastritis—Doxorubicin—uterine cancer	0.00037	0.00068	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000369	0.000677	CcSEcCtD
Darunavir—Muscular weakness—Doxorubicin—uterine cancer	0.000369	0.000677	CcSEcCtD
Darunavir—Dysuria—Epirubicin—uterine cancer	0.000365	0.000671	CcSEcCtD
Darunavir—Neutropenia—Epirubicin—uterine cancer	0.000365	0.000671	CcSEcCtD
Darunavir—Abdominal distension—Doxorubicin—uterine cancer	0.000364	0.000668	CcSEcCtD
Darunavir—Pollakiuria—Epirubicin—uterine cancer	0.000361	0.000663	CcSEcCtD
Darunavir—Eosinophilia—Doxorubicin—uterine cancer	0.000358	0.000657	CcSEcCtD
Darunavir—Paraesthesia—Etoposide—uterine cancer	0.000356	0.000653	CcSEcCtD
Darunavir—Weight increased—Epirubicin—uterine cancer	0.000355	0.000653	CcSEcCtD
Darunavir—Pancreatitis—Doxorubicin—uterine cancer	0.000354	0.000651	CcSEcCtD
Darunavir—Weight decreased—Epirubicin—uterine cancer	0.000353	0.000649	CcSEcCtD
Darunavir—Dyspnoea—Etoposide—uterine cancer	0.000353	0.000649	CcSEcCtD
Darunavir—Hyperglycaemia—Epirubicin—uterine cancer	0.000352	0.000647	CcSEcCtD
Darunavir—Somnolence—Etoposide—uterine cancer	0.000352	0.000647	CcSEcCtD
Darunavir—Angina pectoris—Doxorubicin—uterine cancer	0.000352	0.000647	CcSEcCtD
Darunavir—Infestation NOS—Epirubicin—uterine cancer	0.000348	0.00064	CcSEcCtD
Darunavir—Infestation—Epirubicin—uterine cancer	0.000348	0.00064	CcSEcCtD
Darunavir—Vomiting—Dactinomycin—uterine cancer	0.000348	0.000639	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000345	0.000634	CcSEcCtD
Darunavir—Rash—Dactinomycin—uterine cancer	0.000345	0.000634	CcSEcCtD
Darunavir—Decreased appetite—Etoposide—uterine cancer	0.000344	0.000633	CcSEcCtD
Darunavir—Pancytopenia—Doxorubicin—uterine cancer	0.000343	0.00063	CcSEcCtD
Darunavir—Renal failure—Epirubicin—uterine cancer	0.000342	0.000629	CcSEcCtD
Darunavir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000342	0.000628	CcSEcCtD
Darunavir—Fatigue—Etoposide—uterine cancer	0.000342	0.000627	CcSEcCtD
Darunavir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000341	0.000627	CcSEcCtD
Darunavir—Stomatitis—Epirubicin—uterine cancer	0.000339	0.000623	CcSEcCtD
Darunavir—Jaundice—Epirubicin—uterine cancer	0.000339	0.000623	CcSEcCtD
Darunavir—Pain—Etoposide—uterine cancer	0.000339	0.000622	CcSEcCtD
Darunavir—Constipation—Etoposide—uterine cancer	0.000339	0.000622	CcSEcCtD
Darunavir—Neutropenia—Doxorubicin—uterine cancer	0.000338	0.000621	CcSEcCtD
Darunavir—Dysuria—Doxorubicin—uterine cancer	0.000338	0.000621	CcSEcCtD
Darunavir—Pollakiuria—Doxorubicin—uterine cancer	0.000334	0.000613	CcSEcCtD
Darunavir—Haematuria—Epirubicin—uterine cancer	0.000332	0.00061	CcSEcCtD
Darunavir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000329	0.000605	CcSEcCtD
Darunavir—Weight increased—Doxorubicin—uterine cancer	0.000329	0.000604	CcSEcCtD
Darunavir—Epistaxis—Epirubicin—uterine cancer	0.000328	0.000603	CcSEcCtD
Darunavir—Weight decreased—Doxorubicin—uterine cancer	0.000327	0.0006	CcSEcCtD
Darunavir—Feeling abnormal—Etoposide—uterine cancer	0.000326	0.0006	CcSEcCtD
Darunavir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000326	0.000599	CcSEcCtD
Darunavir—Nausea—Dactinomycin—uterine cancer	0.000325	0.000597	CcSEcCtD
Darunavir—Gastrointestinal pain—Etoposide—uterine cancer	0.000324	0.000595	CcSEcCtD
Darunavir—Infestation NOS—Doxorubicin—uterine cancer	0.000322	0.000592	CcSEcCtD
Darunavir—Infestation—Doxorubicin—uterine cancer	0.000322	0.000592	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000319	0.000587	CcSEcCtD
Darunavir—Bradycardia—Epirubicin—uterine cancer	0.000318	0.000585	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—uterine cancer	0.000317	0.000582	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000316	0.00058	CcSEcCtD
Darunavir—Urticaria—Etoposide—uterine cancer	0.000315	0.000578	CcSEcCtD
Darunavir—Haemoglobin—Epirubicin—uterine cancer	0.000314	0.000577	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—uterine cancer	0.000314	0.000577	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—uterine cancer	0.000314	0.000577	CcSEcCtD
Darunavir—Abdominal pain—Etoposide—uterine cancer	0.000313	0.000575	CcSEcCtD
Darunavir—Body temperature increased—Etoposide—uterine cancer	0.000313	0.000575	CcSEcCtD
Darunavir—Haemorrhage—Epirubicin—uterine cancer	0.000313	0.000574	CcSEcCtD
Darunavir—Hepatitis—Epirubicin—uterine cancer	0.000313	0.000574	CcSEcCtD
Darunavir—Hypoaesthesia—Epirubicin—uterine cancer	0.000311	0.000571	CcSEcCtD
Darunavir—Urinary tract disorder—Epirubicin—uterine cancer	0.000309	0.000567	CcSEcCtD
Darunavir—Oedema peripheral—Epirubicin—uterine cancer	0.000308	0.000566	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—uterine cancer	0.000307	0.000564	CcSEcCtD
Darunavir—Connective tissue disorder—Epirubicin—uterine cancer	0.000307	0.000564	CcSEcCtD
Darunavir—Urethral disorder—Epirubicin—uterine cancer	0.000306	0.000563	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000305	0.00056	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—uterine cancer	0.000304	0.000558	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—uterine cancer	0.000301	0.000553	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—uterine cancer	0.000296	0.000543	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—uterine cancer	0.000294	0.000541	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—uterine cancer	0.000292	0.000537	CcSEcCtD
Darunavir—Hypersensitivity—Etoposide—uterine cancer	0.000292	0.000536	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—uterine cancer	0.000291	0.000534	CcSEcCtD
Darunavir—Flushing—Epirubicin—uterine cancer	0.00029	0.000533	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—uterine cancer	0.00029	0.000533	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—uterine cancer	0.000289	0.000531	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—uterine cancer	0.000289	0.000531	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—uterine cancer	0.000288	0.000529	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000286	0.000525	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—uterine cancer	0.000285	0.000523	CcSEcCtD
Darunavir—Asthenia—Etoposide—uterine cancer	0.000284	0.000522	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000284	0.000522	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—uterine cancer	0.000284	0.000521	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—uterine cancer	0.000284	0.000521	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—uterine cancer	0.000282	0.000519	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—uterine cancer	0.000282	0.000517	CcSEcCtD
Darunavir—Chills—Epirubicin—uterine cancer	0.00028	0.000515	CcSEcCtD
Darunavir—Pruritus—Etoposide—uterine cancer	0.00028	0.000515	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—uterine cancer	0.000279	0.000512	CcSEcCtD
Darunavir—Alopecia—Epirubicin—uterine cancer	0.000276	0.000507	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—uterine cancer	0.000274	0.000503	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—uterine cancer	0.000273	0.000502	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—uterine cancer	0.000272	0.0005	CcSEcCtD
Darunavir—Erythema—Epirubicin—uterine cancer	0.000272	0.0005	CcSEcCtD
Darunavir—Diarrhoea—Etoposide—uterine cancer	0.000271	0.000498	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—uterine cancer	0.00027	0.000496	CcSEcCtD
Darunavir—Flushing—Doxorubicin—uterine cancer	0.000268	0.000493	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—uterine cancer	0.000268	0.000493	CcSEcCtD
Darunavir—Flatulence—Epirubicin—uterine cancer	0.000268	0.000493	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—uterine cancer	0.000266	0.000489	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—uterine cancer	0.000262	0.000482	CcSEcCtD
Darunavir—Dizziness—Etoposide—uterine cancer	0.000262	0.000481	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—uterine cancer	0.000262	0.000481	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—uterine cancer	0.000261	0.00048	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—uterine cancer	0.000261	0.000479	CcSEcCtD
Darunavir—Chills—Doxorubicin—uterine cancer	0.00026	0.000477	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—uterine cancer	0.000256	0.000469	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—uterine cancer	0.000253	0.000465	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—uterine cancer	0.000252	0.000464	CcSEcCtD
Darunavir—Vomiting—Etoposide—uterine cancer	0.000252	0.000463	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—uterine cancer	0.000252	0.000462	CcSEcCtD
Darunavir—Erythema—Doxorubicin—uterine cancer	0.000252	0.000462	CcSEcCtD
Darunavir—Anaemia—Epirubicin—uterine cancer	0.000252	0.000462	CcSEcCtD
Darunavir—Agitation—Epirubicin—uterine cancer	0.00025	0.000459	CcSEcCtD
Darunavir—Rash—Etoposide—uterine cancer	0.00025	0.000459	CcSEcCtD
Darunavir—Dermatitis—Etoposide—uterine cancer	0.00025	0.000458	CcSEcCtD
Darunavir—Headache—Etoposide—uterine cancer	0.000248	0.000456	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—uterine cancer	0.000248	0.000456	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—uterine cancer	0.000247	0.000453	CcSEcCtD
Darunavir—Malaise—Epirubicin—uterine cancer	0.000245	0.000451	CcSEcCtD
Darunavir—Vertigo—Epirubicin—uterine cancer	0.000244	0.000449	CcSEcCtD
Darunavir—Syncope—Epirubicin—uterine cancer	0.000244	0.000448	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—uterine cancer	0.000244	0.000447	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—uterine cancer	0.000242	0.000445	CcSEcCtD
Darunavir—Palpitations—Epirubicin—uterine cancer	0.00024	0.000442	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—uterine cancer	0.000239	0.000439	CcSEcCtD
Darunavir—Cough—Epirubicin—uterine cancer	0.000237	0.000436	CcSEcCtD
Darunavir—Convulsion—Epirubicin—uterine cancer	0.000236	0.000433	CcSEcCtD
Darunavir—Nausea—Etoposide—uterine cancer	0.000235	0.000432	CcSEcCtD
Darunavir—Hypertension—Epirubicin—uterine cancer	0.000235	0.000432	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000234	0.000429	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—uterine cancer	0.000233	0.000427	CcSEcCtD
Darunavir—Chest pain—Epirubicin—uterine cancer	0.000232	0.000426	CcSEcCtD
Darunavir—Myalgia—Epirubicin—uterine cancer	0.000232	0.000426	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—uterine cancer	0.000232	0.000426	CcSEcCtD
Darunavir—Agitation—Doxorubicin—uterine cancer	0.000231	0.000425	CcSEcCtD
Darunavir—Anxiety—Epirubicin—uterine cancer	0.000231	0.000424	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00023	0.000423	CcSEcCtD
Darunavir—Discomfort—Epirubicin—uterine cancer	0.000229	0.00042	CcSEcCtD
Darunavir—Malaise—Doxorubicin—uterine cancer	0.000227	0.000417	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—uterine cancer	0.000227	0.000416	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—uterine cancer	0.000226	0.000416	CcSEcCtD
Darunavir—Syncope—Doxorubicin—uterine cancer	0.000226	0.000415	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—uterine cancer	0.000225	0.000414	CcSEcCtD
Darunavir—Confusional state—Epirubicin—uterine cancer	0.000224	0.000411	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—uterine cancer	0.000222	0.000409	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—uterine cancer	0.000221	0.000406	CcSEcCtD
Darunavir—Cough—Doxorubicin—uterine cancer	0.00022	0.000404	CcSEcCtD
Darunavir—Shock—Epirubicin—uterine cancer	0.000218	0.000401	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—uterine cancer	0.000218	0.000401	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—uterine cancer	0.000218	0.0004	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—uterine cancer	0.000217	0.000399	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—uterine cancer	0.000217	0.000399	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—uterine cancer	0.000217	0.000398	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—uterine cancer	0.000216	0.000396	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—uterine cancer	0.000215	0.000394	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—uterine cancer	0.000214	0.000394	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—uterine cancer	0.000214	0.000394	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—uterine cancer	0.000214	0.000394	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—uterine cancer	0.000214	0.000392	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000213	0.000391	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—uterine cancer	0.000212	0.000389	CcSEcCtD
Darunavir—Anorexia—Epirubicin—uterine cancer	0.000212	0.000389	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—uterine cancer	0.00021	0.000385	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—uterine cancer	0.000207	0.000381	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000202	0.000372	CcSEcCtD
Darunavir—Shock—Doxorubicin—uterine cancer	0.000202	0.000371	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—uterine cancer	0.000202	0.00037	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000201	0.00037	CcSEcCtD
Darunavir—Insomnia—Epirubicin—uterine cancer	0.000201	0.000369	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—uterine cancer	0.000201	0.000368	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—uterine cancer	0.0002	0.000367	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—uterine cancer	0.000199	0.000366	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—uterine cancer	0.000199	0.000365	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—uterine cancer	0.000198	0.000364	CcSEcCtD
Darunavir—Somnolence—Epirubicin—uterine cancer	0.000197	0.000363	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—uterine cancer	0.000196	0.00036	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—uterine cancer	0.000195	0.000359	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—uterine cancer	0.000193	0.000355	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000192	0.000352	CcSEcCtD
Darunavir—Fatigue—Epirubicin—uterine cancer	0.000191	0.000352	CcSEcCtD
Darunavir—Constipation—Epirubicin—uterine cancer	0.00019	0.000349	CcSEcCtD
Darunavir—Pain—Epirubicin—uterine cancer	0.00019	0.000349	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000187	0.000344	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—uterine cancer	0.000186	0.000341	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—uterine cancer	0.000185	0.000339	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—uterine cancer	0.000183	0.000336	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—uterine cancer	0.000183	0.000336	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—uterine cancer	0.000183	0.000336	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000182	0.000334	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—uterine cancer	0.000181	0.000332	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—uterine cancer	0.000179	0.000328	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000177	0.000326	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—uterine cancer	0.000177	0.000325	CcSEcCtD
Darunavir—Urticaria—Epirubicin—uterine cancer	0.000176	0.000324	CcSEcCtD
Darunavir—Constipation—Doxorubicin—uterine cancer	0.000176	0.000323	CcSEcCtD
Darunavir—Pain—Doxorubicin—uterine cancer	0.000176	0.000323	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—uterine cancer	0.000176	0.000322	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—uterine cancer	0.000176	0.000322	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—uterine cancer	0.000169	0.000311	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000168	0.000309	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—uterine cancer	0.000164	0.000301	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—uterine cancer	0.000163	0.0003	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—uterine cancer	0.000162	0.000298	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—uterine cancer	0.000162	0.000298	CcSEcCtD
Darunavir—Asthenia—Epirubicin—uterine cancer	0.000159	0.000293	CcSEcCtD
Darunavir—Pruritus—Epirubicin—uterine cancer	0.000157	0.000289	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—uterine cancer	0.000152	0.000279	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—uterine cancer	0.000151	0.000278	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—uterine cancer	0.000147	0.000271	CcSEcCtD
Darunavir—Dizziness—Epirubicin—uterine cancer	0.000147	0.00027	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—uterine cancer	0.000145	0.000267	CcSEcCtD
Darunavir—Vomiting—Epirubicin—uterine cancer	0.000141	0.000259	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—uterine cancer	0.000141	0.000258	CcSEcCtD
Darunavir—Rash—Epirubicin—uterine cancer	0.00014	0.000257	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—uterine cancer	0.00014	0.000257	CcSEcCtD
Darunavir—Headache—Epirubicin—uterine cancer	0.000139	0.000256	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—uterine cancer	0.000136	0.00025	CcSEcCtD
Darunavir—Nausea—Epirubicin—uterine cancer	0.000132	0.000242	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—uterine cancer	0.000131	0.00024	CcSEcCtD
Darunavir—Rash—Doxorubicin—uterine cancer	0.00013	0.000238	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—uterine cancer	0.000129	0.000238	CcSEcCtD
Darunavir—Headache—Doxorubicin—uterine cancer	0.000129	0.000236	CcSEcCtD
Darunavir—Nausea—Doxorubicin—uterine cancer	0.000122	0.000224	CcSEcCtD
